These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
137 related articles for article (PubMed ID: 6421083)
1. A clinical evaluation of treatment with estriol vaginal cream versus suppository in postmenopausal women. Mattsson LA; Cullberg G Acta Obstet Gynecol Scand; 1983; 62(5):397-401. PubMed ID: 6421083 [TBL] [Abstract][Full Text] [Related]
2. Vaginal absorption of two estriol preparations. A comparative study in postmenopausal women. Mattsson LA; Cullberg G Acta Obstet Gynecol Scand; 1983; 62(5):393-6. PubMed ID: 6421082 [TBL] [Abstract][Full Text] [Related]
3. Ovestin vaginal cream and suppositories for the treatment of menopausal vaginal atrophy. Trevoux R; van der Velden WH; Popović D Reproduccion; 1982; 6(2):101-6. PubMed ID: 7141096 [TBL] [Abstract][Full Text] [Related]
4. The treatment of postmenopausal vaginal atrophy with Ovestin vaginal cream or suppositories: clinical, endocrinological and safety aspects. Kicovic PM; Cortes-Prieto J; Milojević S; Haspels AA; Aljinovic A Maturitas; 1980 Dec; 2(4):275-82. PubMed ID: 6785553 [TBL] [Abstract][Full Text] [Related]
5. A group-comparative study of effects of Ovestin cream versus Premarin cream in post-menopausal women with vaginal atrophy. Luisi M; Franchi F; Kicovic PM Maturitas; 1980 Dec; 2(4):311-9. PubMed ID: 6262604 [TBL] [Abstract][Full Text] [Related]
6. Endocrinological and clinical investigations in post-menopausal women following administration of vaginal cream containing oestriol. Haspels AA; Luisi M; Kicovic PM Maturitas; 1981 Dec; 3(3-4):321-7. PubMed ID: 6801440 [TBL] [Abstract][Full Text] [Related]
7. Plasma estriol and its conjugates following oral and vaginal administration of estriol to postmenopausal women: correlations with gonadotropin levels. Schiff I; Tulchinsky D; Ryan KJ; Kadner S; Levitz M Am J Obstet Gynecol; 1980 Dec; 138(8):1137-41. PubMed ID: 6778214 [TBL] [Abstract][Full Text] [Related]
8. [Postmenopausal vaginal atrophy and topical therapy with an estriol-based ointment (Colpogyn): authors' experience]. Oliva FA; Saltarelli E; D'Antonio GD; Mazzatenta E Minerva Ginecol; 1991 Dec; 43(12):605-7. PubMed ID: 1819780 [TBL] [Abstract][Full Text] [Related]
9. Estriol in the management of the menopause. Tzingounis VA; Aksu MF; Greenblatt RB JAMA; 1978 Apr; 239(16):1638-41. PubMed ID: 633576 [TBL] [Abstract][Full Text] [Related]
10. A Phase II Prospective, Randomized, Double-Blind, Placebo-Controlled and Multicenter Clinical Trial to Assess the Safety of 0.005% Estriol Vaginal Gel in Hormone Receptor-Positive Postmenopausal Women with Early Stage Breast Cancer in Treatment with Aromatase Inhibitor in the Adjuvant Setting. Sánchez-Rovira P; Hirschberg AL; Gil-Gil M; Bermejo-De Las Heras B; Nieto-Magro C Oncologist; 2020 Dec; 25(12):e1846-1854. PubMed ID: 32459035 [TBL] [Abstract][Full Text] [Related]
11. Is vaginal hyaluronic acid as effective as vaginal estriol for vaginal dryness relief? Stute P Arch Gynecol Obstet; 2013 Dec; 288(6):1199-201. PubMed ID: 24178484 [TBL] [Abstract][Full Text] [Related]
12. Continuous low dose estradiol released from a vaginal ring versus estriol vaginal cream for urogenital atrophy. Barentsen R; van de Weijer PH; Schram JH Eur J Obstet Gynecol Reprod Biol; 1997 Jan; 71(1):73-80. PubMed ID: 9031963 [TBL] [Abstract][Full Text] [Related]
13. Low-dose vaginal estrogens or vaginal moisturizer in breast cancer survivors with urogenital atrophy: a preliminary study. Biglia N; Peano E; Sgandurra P; Moggio G; Panuccio E; Migliardi M; Ravarino N; Ponzone R; Sismondi P Gynecol Endocrinol; 2010 Jun; 26(6):404-12. PubMed ID: 20196634 [TBL] [Abstract][Full Text] [Related]
14. Biological effects of various doses of vaginally administered conjugated equine estrogens in postmenopausal women. Mandel FP; Geola FL; Meldrum DR; Lu JH; Eggena P; Sambhi MP; Hershman JM; Judd HL J Clin Endocrinol Metab; 1983 Jul; 57(1):133-9. PubMed ID: 6304131 [TBL] [Abstract][Full Text] [Related]
15. Effects of ospemifene (FC-1271a) on uterine endometrium, vaginal maturation index, and hormonal status in healthy postmenopausal women. Voipio SK; Komi J; Kangas L; Halonen K; DeGregorio MW; Erkkola RU Maturitas; 2002 Nov; 43(3):207-14. PubMed ID: 12443837 [TBL] [Abstract][Full Text] [Related]
16. The effect of transdermal and vaginal estrogen therapy on markers of postmenopausal estrogen status. Gupta P; Ozel B; Stanczyk FZ; Felix JC; Mishell DR Menopause; 2008; 15(1):94-7. PubMed ID: 17882008 [TBL] [Abstract][Full Text] [Related]
17. Low-dose, vaginally administered estrogens may enhance local benefits of systemic therapy in the treatment of urogenital atrophy in postmenopausal women on hormone therapy. Palacios S; Castelo-Branco C; Cancelo MJ; Vázquez F Maturitas; 2005 Feb; 50(2):98-104. PubMed ID: 15653006 [TBL] [Abstract][Full Text] [Related]
18. Effective treatment of vaginal atrophy with isoflavone vaginal gel. Lima SM; Yamada SS; Reis BF; Postigo S; Galvão da Silva MA; Aoki T Maturitas; 2013 Mar; 74(3):252-8. PubMed ID: 23312487 [TBL] [Abstract][Full Text] [Related]
19. Does vaginal estriol make urodynamic changes in women with overactive bladder syndrome and genitourinary syndrome of menopause? Matarazzo MG; Caruso S; Giunta G; Valenti G; Sarpietro G; Cianci A Eur J Obstet Gynecol Reprod Biol; 2018 Mar; 222():75-79. PubMed ID: 29367168 [TBL] [Abstract][Full Text] [Related]
20. Quality of life and sexual function of naturally postmenopausal women on an ultralow-concentration estriol vaginal gel. Caruso S; Cianci S; Amore FF; Ventura B; Bambili E; Spadola S; Cianci A Menopause; 2016 Jan; 23(1):47-54. PubMed ID: 26079974 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]